Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bionano Genomics Q2 EPS $(1.99) Beats $(2.42) Estimate, Sales $6.733M Miss $6.832M Estimate

Author: Benzinga Newsdesk | August 14, 2025 04:34pm
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.42) by 17.6 percent. This is a 86.18 percent increase over losses of $(14.40) per share from the same period last year. The company reported quarterly sales of $6.733 million which missed the analyst consensus estimate of $6.832 million by 1.45 percent. This is a 13.36 percent decrease over sales of $7.771 million the same period last year.

Posted In: BNGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist